Non‑Hormonal Male Birth Control Pill YCT‑529 Declared Safe in Early Human Trial
A non‑hormonal male birth control pill, YCT‑529, has completed its first Phase 1a human trial, showing no serious side effects and…
News That Matters, Always
A non‑hormonal male birth control pill, YCT‑529, has completed its first Phase 1a human trial, showing no serious side effects and…
As summer unfolds across the United States, COVID-19 cases are once again on the rise. According to The Times of…
A recently published research study has reignited global discussion on the safety of COVID-19 vaccines, focusing specifically on the widely…
Cholesterol is a waxy, fat-like substance present in the blood. While the body needs cholesterol to build healthy cells, excess…
In a major leap toward universal child healthcare, India has managed to reduce the number of zero-dose children—those who have…
If you think melting stubborn lower belly fat demands hours at the gym or hundreds of crunches, think again. As…
The United Nations has issued a dire warning that millions could die by 2029 if US funding for HIV programs…
Switzerland’s medical regulatory authority, Swissmedic, has granted approval for Coartem Baby, the first antimalarial drug specifically designed for newborns and…
Photo Credit: Financial Express A comprehensive meta-analysis has revealed that individuals with blood type A face a 16% higher risk…
PCOS Among Teenage Girls Photo Credit: indiatoday With PCOS (Polycystic Ovary Syndrome) cases rising alarmingly among teenage girls, a new…